Definity Rt Injection, Suspension
NDC Package 11994-017-01
Package Information
Definity Rt (perflutren) injection is activated DEFINITY RT (Perflutren Lipid Microsphere) Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. This formulation utilizes a injection, suspension delivery system. Marketed by Lantheus Medical Imaging, Inc., this product is identified by NDC 11994-017 and is authorized under FDA application NDA021064.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11994 - Lantheus Medical Imaging, Inc.
- 11994-017 - Definity Rt
- 11994-017-01 - 1 VIAL, GLASS in 1 CARTON / .35 mL in 1 VIAL, GLASS
- 11994-017 - Definity Rt
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11994-017). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11994-017-01 identifies a specific commercial package of 1 vial, glass in 1 carton / .35 ml in 1 vial, glass of Definity Rt, a human prescription drug labeled by Lantheus Medical Imaging, Inc.. This injection, suspension is formulated for intravenous use and contains perflutren as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lantheus Medical Imaging, Inc. on October 01, 2020. The current certification is valid through December 31, 2026.
How is this Lantheus Medical Imaging, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11994001701. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.